tiprankstipranks
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
US Market
STRO
Sutro Biopharma
RESEARCH TOOLSreports
Want to see STRO full AI Analyst Report?

Sutro Biopharma (STRO) Income Statement

720 Followers

Sutro Biopharma Income Statement

Last quarter (Q4 2025), Sutro Biopharma's total revenue was $11.65M, a decrease of -21.35% from the same quarter last year. In Q4, Sutro Biopharma's net income was $-46.76M. See Sutro Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 102.48M$ 62.04M$ 153.73M$ 67.77M$ 61.88M
Gross Profit
$ 95.16M$ 54.83M$ 146.91M$ 59.48M$ 52.11M
Operating Expenses
$ 200.11M$ 293.28M$ 236.19M$ 188.43M$ 150.63M
Depreciation and Amortization
$ 7.32M$ 7.22M$ 6.82M$ 8.29M$ 4.84M
EBITDA
$ -97.63M$ -180.45M$ -67.92M$ -105.07M$ -97.56M
Operating Income
$ -104.95M$ -238.45M$ -89.28M$ -128.94M$ -98.52M
Other Income/Expenses
$ -86.23M$ 13.36M$ 677.00K$ 12.24M$ -7.01M
Pretax Income
$ -191.18M$ -225.10M$ -88.60M$ -116.70M$ -105.54M
Net Income
$ -191.09M$ -227.46M$ -106.79M$ -119.20M$ -105.54M
Per Share Metrics
Basic EPS
$ -22.49$ -29.60$ -17.80$ -23.50$ -22.90
Diluted EPS
$ -22.49$ -29.60$ -17.80$ -23.50$ -22.90
Weighted Average Shares Outstanding
 8.50M 7.68M 6.02M 5.07M 4.61M
Weighted Average Shares Outstanding (Diluted)
 8.50M 7.68M 6.02M 5.07M 4.61M
Currency in USD

Sutro Biopharma Earnings and Revenue History